GMED compared with PTCT: revenue, margins and what each company keeps, and the suppliers and customers both name

GMEDGlobus Medical Inc

Mkt capRevenueRevenue

PTCTPTC Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

GMEDGlobus Medical Inc

PTCTPTC Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

GMED2 of 4 reports

1 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±9.8%▼−12.76%×1.31

Q2 FY26—▲+1.57%—

PTCT

1 of 4at or beyond implied

Reportimpliedrealized× implied

Oct 30 '26±12.0%▼−6.97%×0.58

Q2 FY26±11.6%▼−9.94%×0.85

= impliedGMED realized, solidPTCT realized, hatchedOne scale, both sides: full bar = 15%× = |realized| ÷ impliedspan: GMED 91d · PTCT 252dSource: market data

Q1 FY26

±9.4%

▲+14.27%

×1.52

Feb 20 '26±4.3%▲+1.09%×0.26

GMEDGlobus Medical Inc

70.94▼−12.89%· post 71.30

Mkt cap$9.4BRevenue$764MQ3 FY26Revenue$2.9BFY25

PTCTPTC Therapeutics, Inc.

65.49▼−0.27%· post 65.50

ClosedNov 6 '26

Mkt cap$5.5BRevenue$361MQ2 FY26Revenue$1.7BFY25

Compare

ClosedNov 6 '26

GMEDGlobus Medical Inc

PTCTPTC Therapeutics, Inc.

70.94▼−12.89%post 71.30

Price

65.49▼−0.27%post 65.50

$9.4B

Mkt cap

$5.5B

Q3 FY26$764M

Revenue

$361MQ2 FY26

FY25$2.9B

Revenue

$1.7BFY25

GMED70.94▼−12.89%vsPTCT65.49▼−0.27%ClosedNov 6 '26